参考文献/References:
[1] Peiris AN,Chaljub E,Medlock D.Endometriosis[J].JAMA,2018,320(24):2608.
[2] Burney RO,Giudice LC.Reprint of:Pathogenesis and pathophysiology of endometriosis[J].Fertility and Sterility,2019,112(41):153-161.
[3] Saha R,Pettersson HJ,Svedberg P,et al.Heritability of endometriosis[J].Fertility and Sterility,2015,104(4):947-952.
[4] George N,Goulielmos,Michail,et al.Endometriosis research in the -omics era[J].Gene,2020,741:144545.
[5] Zhao W,Kang S,Wang L,et al.Aberrant methylation of the IL-12B promotor region contributes to the risk of developing ovarian endometriosis[J].Molecular Reproduction and Development,2019,86(6):1-7.
[6] Kang YJ,Jeung IC,Park A,et al.An increased level of IL-6 suppresses NK cell activity in peritoneal fluid of patients with endometriosis via regulation of SHP-2 expression[J].Human reproduction(Oxford,England),2014,29(10):2176-2189.
[7] Ahn SH,Monsanto SP,Miller C,et al.Pathophysiology and immune dysfunction in endometriosis[J].BioMed Research International,2015,2015:1-12.
[8] Casper RF.Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills[J].Fertility and Sterility,2017,107(3):533-536.
[9] Becker CM,Beaudry P,Funakoshi T,et al.Circulating endothelial progenitor cells are up-regulated in a mouse model of endometriosis[J].The American Journal of Pathology,2011,178(4):1782-1791.
[10] Bulun SE,Cheng YH,Yin P,et al.Progesterone resistance in endometriosis:Link to failure to metabolize estradiol[J].Molecular and Cellular Endocrinology,2006,248(1-2):94-103.
[11] Samimi M,Mehdizadehkashi A,Eftekhar T,et al.The role of inflammation,oxidative stress,angiogenesis,and apoptosis in the pathophysiology of endometriosis:Basic science and new insights based on gene expression[J].Journal of Cellular Physiology,2019,234(11):1-9.
[12] Leonardi M,Hicks C,El-Assaad F,et al.Endometriosis and the microbiome:A systematic review[J].BJOG.2020,127(2):239-249.
[13] 李丹萍,吴英杰.子宫内膜异位症药物治疗的研究进展[J].广东化工,2020,47(3):145-146.
[14] Ng J,Chwalisz K,Carter DC,et al.Dose-dependent suppression of gonadotropins and ovarian hormones by elagolix in healthy premenopausal women[J].The Journal of Clinical Endocrinology and Metabolism,2017,102(5):1683-1691.
[15] Markham A.Relugolix:First global approval[J].Drugs,2019,79(6):675-679.
[16] Zulfikaroglu E,Sevtap Klc,Islimye M,et al.Efficacy of antitumor necrosis factor therapy on endometriosis in an experimental rat model[J].Arch Gynecol Obstet,2011,283(4):799-804.
[17] Liu Y,Qin X,Lu X.Effects of inhibiting the PI3K/Akt/mTOR signaling pathway on the pain of sciatic endometriosis in a rat model[J].Can J Physiol Pharmacol,2019,97(10):1-8.
[18] Antonio LGL,Rosa-E-Silva JC,Machado DJ,et al.Thalidomide reduces cell proliferation in endometriosis experimentally induced in rats[J].Rev Bras Ginecol Obstet,2019,41(11):668-672.
[19] Akyol A,Simsek M,Ilhan R,et al.Efficacies of vitamin D and omega3 polyunsaturated fatty acids on experimental endometriosis[J].Taiwan J Obstet Gynecol,2016,55(6):835-839.
[20] Rocha AL,Reis FM,Petraglia F.New trends for the medical treatment of endometriosis[J].Expert Opinion on Investigational Drugs,2012,21(7):905-919.
[21] Yilmaz B,Ozat M,Kilic S,et al.Atorvastatin causes regression of endometriotic implants in a rat model[J].Reprod Biomed Online,2010,20(2):291-299.
[22] 张丽华.开腹与腹腔镜治疗子宫内膜异位症合并不孕症的影响评价[J].当代医学,2020,26(12):52-54.
[23] Zhu MB,Chen LP,Hu M,et al.Effects of lncRNA BANCR on endometriosis through ERK/MAPK pathway[J].Eur Rev Med Pharmacol Sci,2019,23(16):6806-6812.
[24] Borghese B,Zondervan KT,Abrao MS,et al.Recent insights on the genetics and epigenetics of endometriosis[J].Clin Genet,2017,91(2):254-264.
[25] 王 媛.活血消癥汤治疗子宫内膜异位症的临床疗效[J].内蒙古中医药 2019,38(11):63-64.
[26] 李田田,孙伟伟,赵瑞华.活血消异方对子宫内膜异位症大鼠盆腔粘连及转化生长因子-β1的影响[J].实验动物科学,2018,35(6),15-21.
[27] 杭 颖,李立华.自拟祛痰化痰消癥方治疗子宫内膜异位症疗效评价[J].北京中医药,2017,36(1):79-81.
[28] 张 莉,金 晶,季 菲.丹莪妇康煎膏联合孕三烯酮治疗子宫内膜异位症疗效及对患者CA125、TNF-α和IL-6水平的影响[J].陕西中医,2020,41(10):1370-1372.
[29] 谭妙群,黄春凤.醋酸甲轻孕酮联合行气逐瘀止痛方治疗气滞血瘀型子宫内膜异位症的临床疗效观察[J].中国医学工程,2016,24(8):78.
[30] 祝 捷.当归四逆汤加减治疗寒凝血瘀型子宫内膜异位症的临床研究[J].湖北中医药大学学报,2016,18(3):33-35.
[31] 刘 枚.少腹逐瘀汤联合孕三稀酮治疗子宫内膜异位症前瞻性研究[J].陕西中医,2020,41(3):342-345.
[32] 程 芳,马金雨,马希佳,等.王自平应用补肾化瘀法治疗子宫内膜异位症[J].中医学报,2020,35(5):1011-1015.
[33] 李 琳.补肾活血化瘀法对子宫内膜异位症血流变学及性激素水平的影响[J].中医临床研究,2019,11(31):92-94.
[34] 何 珏,徐 妍,顾 颖.清热化瘀方对瘀热互结型子宫内膜异位症患者疼痛及凝血功能的影响[J].河北中医,2020,42(1):16-21,41.
[35] 万德馨,张敏鸽,党 群,等.红藤汤灌肠联合外敷治疗子宫内膜异位症保守手术后痛经的临床疗效[J].陕西中医,2016,37(10):1289-1290.
相似文献/References:
[1]胡贞君,刘笑梅△,曹保利.复方莪术散治疗子宫内膜异位症疗效及其分子学研究进展*[J].陕西中医,2019,(9):1315.
[2]严 莉,李 晶,黎玉宣,等.腹针联合脐疗对黄体功能低下型不孕症患者子宫内膜容受性的影响*[J].陕西中医,2020,(5):673.[doi:DOI:10.3969/j.issn.10007369.2020.05.034]
YAN Li,LI Jing,LI Yuxuan,et al.The influence of abdominal acupuncture combined with umbilical therapy on endometrial receptivity in infertility patients caused by luteal phase deficiency[J].,2020,(10):673.[doi:DOI:10.3969/j.issn.10007369.2020.05.034]
[3]樊健敏,田 颖,白永利△,等.补肾活血汤对小卵泡排卵不孕症患者卵泡发育、卵巢动脉血流的影响*[J].陕西中医,2020,(10):1367.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.006]
FAN Jianmin,TIAN Ying,BAI Yongli,et al.Effect of Bushen Huoxue decoction on follicular development and ovarian artery blood flow in infertile patients with small follicle ovulation[J].,2020,(10):1367.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.006]
[4]张 莉,金 晶,季 菲△.丹莪妇康煎膏联合孕三烯酮治疗子宫内膜异位症疗效及对患者CA125、TNF-α和IL-6水平的影响*[J].陕西中医,2020,(10):1370.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.007]
[5]李承秋,吕文艺,金 凡,等.活血消异汤联合米非司酮对子宫内膜异位症患者血清MMP-3、CA125、EMAb水平的影响[J].陕西中医,2021,(3):297.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.006]
LI Chengqiu,LV Wenyi,JIN Fan,et al.Effect of Huoxue Xiaoyi decoction combined with mifepristone on the serum levels of MMP-3,CA125 and EMAb in patients with endometriosis[J].,2021,(10):297.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.006]
[6]凌丹凤,马丽然.补肾活血除湿法治疗早发性卵巢功能不全不孕症临床研究[J].陕西中医,2021,(12):1717.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.016]
LING Danfeng,MA Liran.Clinical observation on the treatment of early-onset ovarian insufficiency infertility with Bushen Huoxue Chushi method[J].,2021,(10):1717.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.016]
[7]余 震,柳 洲.消瘤方对子宫内膜异位症大鼠盆腔粘连的影响[J].陕西中医,2022,(1):13.[doi:DOI:10.3969/j.issn.1000-7369.2022.01.003]
YU Zhen,LIU Zhou.Effect and the mechanism of Xiaoliu decoction on pelvic adhesion in rats with endometriosis[J].,2022,(10):13.[doi:DOI:10.3969/j.issn.1000-7369.2022.01.003]
[8]董秀娟,曹若愚,于洪基,等.大蒜素对子宫内膜异位症大鼠异位病灶及缺氧诱导因子-1α表达的影响[J].陕西中医,2022,(4):432.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.005]
DONG Xiujuan,CAO Ruoyu,YU Hongji,et al.Effects of Allicin on the ectopic lesions and the expression of HIF-1α in rats with endometriosis[J].,2022,(10):432.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.005]
[9]赵 娜,周灵雪,杨向荣.桂枝茯苓胶囊联合戈舍瑞林对子宫内膜异位症患者子宫动脉血流动力学及Th1/Th2细胞因子的影响[J].陕西中医,2022,(4):446.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.008]
ZHAO Na,ZHOU Lingxue,YANG Xiangrong.Effects of Guizhi Fuling capsule combined with goserelin on uterine artery hemodynamics and Th1/Th2 cytokines in endometriosis patients[J].,2022,(10):446.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.008]
[10]刘 叶,赵亚芹.活血通络解毒汤治疗子宫内膜异位症疗效及对患者卵巢功能的影响[J].陕西中医,2022,(4):450.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.009]
LIU Ye,ZHAO Yaqin.Therapeutic effect of Huoxue Tongluo Jiedu decoction on endometriosis and its influence on ovarian function of patients[J].,2022,(10):450.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.009]